Neuropeptide VGF promotes maturation of hippocampal dendrites that is reduced by single nucleotide polymorphisms

International Journal of Molecular Sciences

Volumn 18, Issue 3, 2017, Pages

  Behnke, Joseph ^a   Cheedalla, Aneesha ^a   Bhatt, Vatsal ^a   Bhat, Maysa ^a   Teng, Shavonne ^a   Palmieri, Alicia ^a   Windon, Charles Christian ^a   Thakker Varia, Smita ^a   Alder, Janet ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Dendrite; Hippocampus; Neuropeptide; Single nucleotide polymorphism; Spine; Synapse

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEUROPEPTIDE; SYNAPTOTAGMIN; PEPTIDE; TLQP62 PEPTIDE; VGF PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENDRITIC SPINE; GENETIC TRANSFECTION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MORPHOLOGICAL TRAIT; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PLASMID; POINT MUTATION; POLYMERASE CHAIN REACTION; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC POTENTIAL; PROTEIN EXPRESSION; RAT; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS; STOP CODON; SYNAPTIC EFFICACY; UPREGULATION; WESTERN BLOTTING; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; CELL LINE; DENDRITE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; PYRAMIDAL NERVE CELL; SYNAPSE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CELLS, CULTURED; DENDRITES; GENE EXPRESSION; HIPPOCAMPUS; HUMANS; NEUROPEPTIDES; PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRAMIDAL CELLS; RATS; SYNAPSES;

EID: 85015184731     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18030612     Document Type: Article

References (90)

1. Alder, J.; Thakker-Varia, S.; Bangasser, D.A.; Kuroiwa, M.; Plummer, M.R.; Shors, T.J.; Black, I.B. Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J. Neurosci. 2003, 23, 10800–10808. [PubMed]
2. Trani, E.; Giorgi, A.; Canu, N.; Amadoro, G.; Rinaldi, A.M.; Halban, P.A.; Ferri, G.L.; Possenti, R.; Schinina, M.E.; Levi, A. Isolation and characterization of VGF peptides in rat brain. Role of PC1/3 and PC2 in the maturation of VGF precursor. J. Neurochem. 2002, 81, 565–574. [CrossRef] [PubMed]
3. Bartolomucci, A.; La Corte, G.; Possenti, R.; Locatelli, V.; Rigamonti, A.E.; Torsello, A.; Bresciani, E.; Bulgarelli, I.; Rizzi, R.; Pavone, F.; et al. TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity. Proc. Natl. Acad. Sci. USA 2006, 103, 14584–14589. [CrossRef] [PubMed]
4. Hahm, S.; Mizuno, T.M.; Wu, T.J.; Wisor, J.P.; Priest, C.A.; Kozak, C.A.; Boozer, C.N.; Peng, B.; McEvoy, R.C.; Good, P.; et al. Targeted deletion of the VGF gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron 1999, 23, 537–548. [CrossRef]
5. Watson, E.; Hahm, S.; Mizuno, T.M.; Windsor, J.; Montgomery, C.; Scherer, P.E.; Mobbs, C.V.; Salton, S.R. VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity. Endocrinology 2005, 146, 5151–5163. [CrossRef] [PubMed]
6. Foglesong, G.D.; Huang, W.; Liu, X.; Slater, A.M.; Siu, J.; Yildiz, V.; Salton, S.R.; Cao, L. Role of Hypothalamic VGF in Energy Balance and Metabolic Adaption to Environmental Enrichment in Mice. Endocrinology 2016, 157, 983–996. [CrossRef] [PubMed]
7. Sadahiro, M.; Erickson, C.; Lin, W.J.; Shin, A.C.; Razzoli, M.; Jiang, C.; Fargali, S.; Gurney, A.; Kelley, K.A.; Buettner, C.; et al. Role of VGF-derived carboxy-terminal peptides in energy balance and reproduction: Analysis of "humanized" knockin mice expressing full-length or truncated VGF. Endocrinology 2015, 156, 1724–1738. [CrossRef] [PubMed]
8. Moss, A.; Ingram, R.; Koch, S.; Theodorou, A.; Low, L.; Baccei, M.; Hathway, G.J.; Costigan, M.; Salton, S.R.; Fitzgerald, M. Origins, actions and dynamic expression patterns of the neuropeptide VGF in rat peripheral and central sensory neurones following peripheral nerve injury. Mol. Pain 2008, 4, 62. [CrossRef] [PubMed]
9. Riedl, M.S.; Braun, P.D.; Kitto, K.F.; Roiko, S.A.; Anderson, L.B.; Honda, C.N.; Fairbanks, C.A.; Vulchanova, L. Proteomic analysis uncovers novel actions of the neurosecretory protein VGF in nociceptive processing. J. Neurosci. 2009, 29, 13377–13388. [CrossRef] [PubMed]
10. Rizzi, R.; Bartolomucci, A.; Moles, A.; D’Amato, F.; Sacerdote, P.; Levi, A.; La Corte, G.; Ciotti, M.T.; Possenti, R.; Pavone, F. The VGF-derived peptide TLQP-21: A new modulatory peptide for inflammatory pain. Neurosci. Lett. 2008, 441, 129–133. [CrossRef] [PubMed]
11. Bartolomucci, A.; Pasinetti, G.M.; Salton, S.R. Granins as disease-biomarkers: Translational potential for psychiatric and neurological disorders. Neuroscience 2010, 170, 289–297. [CrossRef] [PubMed]
12. Cocco, C.; D’Amato, F.; Noli, B.; Ledda, A.; Brancia, C.; Bongioanni, P.; Ferri, G.L. Distribution of VGF peptides in the human cortex and their selective changes in Parkinson’s and Alzheimer’s diseases. J. Anat. 2010, 217, 683–693. [CrossRef] [PubMed]
13. Shimazawa, M.; Tanaka, H.; Ito, Y.; Morimoto, N.; Tsuruma, K.; Kadokura, M.; Tamura, S.; Inoue, T.; Yamada, M.; Takahashi, H.; et al. An inducer of VGF protects cells against ER stress-induced cell death and prolongs survival in the mutant SOD1 animal models of familial ALS. PLoS ONE 2010, 5, e15307. [CrossRef] [PubMed]
14. Zhao, Z.; Lange, D.J.; Ho, L.; Bonini, S.; Shao, B.; Salton, S.R.; Thomas, S.; Pasinetti, G.M. Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (ALS), with a potential role in disease pathogenesis. Int. J. Med. Sci. 2008, 5, 92–99. [CrossRef] [PubMed]
15. Razzoli, M.; Bo, E.; Pascucci, T.; Pavone, F.; D’Amato, F.R.; Cero, C.; Sanghez, V.; Dadomo, H.; Palanza, P.; Parmigiani, S.; et al. Implication of the VGF-derived peptide TLQP-21 in mouse acute and chronic stress responses. Behav. Brain Res. 2012, 229, 333–339. [CrossRef] [PubMed]
16. Ramos, A.; Rodriguez-Seoane, C.; Rosa, I.; Trossbach, S.V.; Ortega-Alonso, A.; Tomppo, L.; Ekelund, J.; Veijola, J.; Jarvelin, M.R.; Alonso, J.; et al. Neuropeptide precursor VGF is genetically associated with social anhedonia and underrepresented in the brain of major mental illness: Its downregulation by DISC1. Hum. Mol. Genet. 2014, 23, 5859–5865. [CrossRef] [PubMed]
17. Cattaneo, A.; Sesta, A.; Calabrese, F.; Nielsen, G.; Riva, M.A.; Gennarelli, M. The Expression of VGF is Reduced in Leukocytes of Depressed Patients and it is Restored by Effective Antidepressant Treatment. Neuropsychopharmacology 2010, 35, 1423–1428. [CrossRef] [PubMed]
18. Levi, A.; Ferri, G.L.; Watson, E.; Possenti, R.; Salton, S.R. Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor. Cell. Mol. Neurobiol. 2004, 24, 517–533. [CrossRef] [PubMed]
19. Snyder, S.E.; Cheng, H.W.; Murray, K.D.; Isackson, P.J.; McNeill, T.H.; Salton, S.R. The messenger RNA encoding VGF, a neuronal peptide precursor, is rapidly regulated in the rat central nervous system by neuronal activity, seizure and lesion. Neuroscience 1998, 82, 7–19. [CrossRef]
20. Karege, F.; Perret, G.; Bondolfi, G.; Schwald, M.; Bertschy, G.; Aubry, J.M. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002, 109, 143–148. [CrossRef]
21. Shimizu, E.; Hashimoto, K.; Watanabe, H.; Komatsu, N.; Okamura, N.; Koike, K.; Shinoda, N.; Nakazato, M.; Kumakiri, C.; Okada, S.; et al. Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls. Neurosci. Lett. 2003, 351, 111–114. [CrossRef] [PubMed]
22. Angelucci, F.; Mathe, A.A.; Aloe, L. Neurotrophic factors and CNS disorders: Findings in rodent models of depression and schizophrenia. Prog. Brain Res. 2004, 146, 151–165. [PubMed]
23. Thakker-Varia, S.; Krol, J.J.; Nettleton, J.; Bilimoria, P.M.; Bangasser, D.A.; Shors, T.J.; Black, I.B.; Alder, J. The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J. Neurosci. 2007, 27, 12156–12167. [CrossRef] [PubMed]
24. Hunsberger, J.G.; Newton, S.S.; Bennett, A.H.; Duman, C.H.; Russell, D.S.; Salton, S.R.; Duman, R.S. Antidepressant actions of the exercise-regulated gene VGF. Nat. Med. 2007, 13, 1476–1482. [CrossRef] [PubMed]
25. Lin, P.; Wang, C.; Xu, B.; Gao, S.; Guo, J.; Zhao, X.; Huang, H.; Zhang, J.; Chen, X.; Wang, Q.; et al. The VGF-derived peptide TLQP62 produces antidepressant-like effects in mice via the BDNF/TrkB/CREB signaling pathway. Pharmacol. Biochem. Behav. 2014, 120, 140–148. [CrossRef] [PubMed]
26. Lu, Y.; Wang, C.; Xue, Z.; Li, C.; Zhang, J.; Zhao, X.; Liu, A.; Wang, Q.; Zhou, W. PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13. Int. J. Neuropsychopharmacol. 2014, 18. [CrossRef] [PubMed]
27. Thakker-Varia, S.; Jean, Y.Y.; Parikh, P.; Sizer, C.F.; Jernstedt Ayer, J.; Parikh, A.; Hyde, T.M.; Buyske, S.; Alder, J. The neuropeptide VGF is reduced in human bipolar postmortem brain and contributes to some of the behavioral and molecular effects of lithium. J. Neurosci. 2010, 30, 9368–9380. [CrossRef] [PubMed]
28. Qiao, H.; Li, M.X.; Xu, C.; Chen, H.B.; An, S.C.; Ma, X.M. Dendritic Spines in Depression: What We Learned from Animal Models. Neural Plast. 2016, 2016, 8056370. [CrossRef] [PubMed]
29. Neumeister, A.; Wood, S.; Bonne, O.; Nugent, A.C.; Luckenbaugh, D.A.; Young, T.; Bain, E.E.; Charney, D.S.; Drevets, W.C. Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects. Biol. Psychiatry 2005, 57, 935–937. [CrossRef] [PubMed]
30. Duric, V.; Banasr, M.; Stockmeier, C.A.; Simen, A.A.; Newton, S.S.; Overholser, J.C.; Jurjus, G.J.; Dieter, L.; Duman, R.S. Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int. J. Neuropsychopharmacol. 2013, 16, 69–82. [CrossRef] [PubMed]
31. Pittenger, C.; Duman, R.S. Stress, depression, and neuroplasticity: A convergence of mechanisms. Neuropsychopharmacology 2008, 33, 88–109. [CrossRef] [PubMed]
32. Czeh, B.; Simon, M.; Schmelting, B.; Hiemke, C.; Fuchs, E. Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 2006, 31, 1616–1626. [CrossRef] [PubMed]
33. Rocher, C.; Spedding, M.; Munoz, C.; Jay, T.M. Acute stress-induced changes in hippocampal/prefrontal circuits in rats: Effects of antidepressants. Cereb Cortex 2004, 14, 224–229. [CrossRef] [PubMed]
34. Kellner, Y.; Godecke, N.; Dierkes, T.; Thieme, N.; Zagrebelsky, M.; Korte, M. The BDNF effects on dendritic spines of mature hippocampal neurons depend on neuronal activity. Front. Synaptic Neurosci. 2014, 6, 5. [CrossRef] [PubMed]
35. Bennett, M.R.; Lagopoulos, J. Stress and trauma: BDNF control of dendritic-spine formation and regression. Prog. Neurobiol. 2014, 112, 80–99. [CrossRef] [PubMed]
36. Magarinos, A.M.; Li, C.J.; Gal Toth, J.; Bath, K.G.; Jing, D.; Lee, F.S.; McEwen, B.S. Effect of brain-derived neurotrophic factor haploinsufficiency on stress-induced remodeling of hippocampal neurons. Hippocampus 2011, 21, 253–264. [CrossRef] [PubMed]
37. Thakker-Varia, S.; Behnke, J.; Doobin, D.; Dalal, V.; Thakkar, K.; Khadim, F.; Wilson, E.; Palmieri, A.; Antila, H.; Rantamaki, T.; et al. VGF (TLQP-62)-induced neurogenesis targets early phase neural progenitor cells in the adult hippocampus and requires glutamate and BDNF signaling. Stem Cell Res. 2014, 12, 762–777. [CrossRef] [PubMed]
38. Yang, D.; Zhang, W.; Padhiar, A.; Yue, Y.; Shi, Y.; Zheng, T.; Davis, K.; Zhang, Y.; Huang, M.; Li, Y.; et al. NPAS3 Regulates Transcription and Expression of VGF: Implications for Neurogenesis and Psychiatric Disorders. Front. Mol. Neurosci. 2016, 9, 109. [CrossRef] [PubMed]
39. Mead, B.; Logan, A.; Berry, M.; Leadbeater, W.; Scheven, B.A. Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: Comparison with human bone marrow and adipose-derived mesenchymal stem cells. PLoS ONE 2014, 9, e109305. [CrossRef] [PubMed]
40. Severini, C.; Ciotti, M.T.; Biondini, L.; Quaresima, S.; Rinaldi, A.M.; Levi, A.; Frank, C.; Possenti, R. TLQP-21, a neuroendocrine VGF-derived peptide, prevents cerebellar granule cells death induced by serum and potassium deprivation. J. Neurochem. 2008, 104, 534–544. [PubMed]
41. van den Pol, A.N. Neuropeptide transmission in brain circuits. Neuron 2012, 76, 98–115. [CrossRef] [PubMed]
42. Altar, C.A.; Laeng, P.; Jurata, L.W.; Brockman, J.A.; Lemire, A.; Bullard, J.; Bukhman, Y.V.; Young, T.A.; Charles, V.; Palfreyman, M.G. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J. Neurosci. 2004, 24, 2667–2677. [CrossRef] [PubMed]
43. Hevroni, D.; Rattner, A.; Bundman, M.; Lederfein, D.; Gabarah, A.; Mangelus, M.; Silverman, M.A.; Kedar, H.; Naor, C.; Kornuc, M.; et al. Hippocampal plasticity involves extensive gene induction and multiple cellular mechanisms. J. Mol. Neurosci. 1998, 10, 75–98. [CrossRef] [PubMed]
44. Newton, S.S.; Collier, E.F.; Hunsberger, J.; Adams, D.; Terwilliger, R.; Selvanayagam, E.; Duman, R.S. Gene profile of electroconvulsive seizures: Induction of neurotrophic and angiogenic factors. J. Neurosci. 2003, 23, 10841–10851. [PubMed]
45. Bozdagi, O.; Rich, E.; Tronel, S.; Sadahiro, M.; Patterson, K.; Shapiro, M.L.; Alberini, C.M.; Huntley, G.W.; Salton, S.R. The neurotrophin-inducible gene VGF regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism. J. Neurosci. 2008, 28, 9857–9869. [CrossRef] [PubMed]
46. Lin, W.J.; Jiang, C.; Sadahiro, M.; Bozdagi, O.; Vulchanova, L.; Alberini, C.M.; Salton, S.R. VGF and Its C-Terminal Peptide TLQP-62 Regulate Memory Formation in Hippocampus via a BDNF-TrkB-Dependent Mechanism. J. Neurosci. 2015, 35, 10343–10356. [CrossRef] [PubMed]
47. Noli, B.; Brancia, C.; Pilleri, R.; D’Amato, F.; Messana, I.; Manconi, B.; Ebling, F.J.; Ferri, G.L.; Cocco, C. Photoperiod Regulates VGF-Derived Peptide Processing in Siberian Hamsters. PLoS ONE 2015, 10, e0141193. [CrossRef] [PubMed]
48. D’Amato, F.; Noli, B.; Angioni, L.; Cossu, E.; Incani, M.; Messana, I.; Manconi, B.; Solinas, P.; Isola, R.; Mariotti, S.; et al. VGF Peptide Profiles in Type 2 Diabetic Patients’ Plasma and in Obese Mice. PLoS ONE 2015, 10, e0142333. [CrossRef] [PubMed]
49. Sato, H.; Fukutani, Y.; Yamamoto, Y.; Tatara, E.; Takemoto, M.; Shimamura, K.; Yamamoto, N. Thalamus-derived molecules promote survival and dendritic growth of developing cortical neurons. J. Neurosci. 2012, 32, 15388–15402. [CrossRef] [PubMed]
50. Sakamoto, M.; Miyazaki, Y.; Kitajo, K.; Yamaguchi, A. VGF, Which Is Induced Transcriptionally in Stroke Brain, Enhances Neurite Extension and Confers Protection Against Ischemia In Vitro. Transl. Stroke Res. 2015, 6, 301–308. [CrossRef] [PubMed]
51. Chen, Y.C.; Pristera, A.; Ayub, M.; Swanwick, R.S.; Karu, K.; Hamada, Y.; Rice, A.S.; Okuse, K. Identification of a receptor for neuropeptide VGF and its role in neuropathic pain. J. Biol. Chem. 2013, 288, 34638–34646. [CrossRef] [PubMed]
52. Hannedouche, S.; Beck, V.; Leighton-Davies, J.; Beibel, M.; Roma, G.; Oakeley, E.J.; Lannoy, V.; Bernard, J.; Hamon, J.; Barbieri, S.; et al. Identification of the C3a receptor (C3AR1) as the target of the VGF-derived peptide TLQP-21 in rodent cells. J. Biol. Chem. 2013, 288, 27434–27443. [CrossRef] [PubMed]
53. Peterson, S.L.; Nguyen, H.X.; Mendez, O.A.; Anderson, A.J. Complement protein C1q modulates neurite outgrowth in vitro and spinal cord axon regeneration in vivo. J. Neurosci. 2015, 35, 4332–4349. [CrossRef] [PubMed]
54. Bartolomucci, A.; Possenti, R.; Mahata, S.K.; Fischer-Colbrie, R.; Loh, Y.P.; Salton, S.R. The extended granin family: Structure, function, and biomedical implications. Endocr. Rev. 2011, 32, 755–797. [CrossRef] [PubMed]
55. Dijkhuizen, P.A.; Ghosh, A. BDNF regulates primary dendrite formation in cortical neurons via the PI3-kinase and MAP kinase signaling pathways. J. Neurobiol. 2005, 62, 278–288. [CrossRef] [PubMed]
56. Yoshimura, T.; Kawano, Y.; Arimura, N.; Kawabata, S.; Kikuchi, A.; Kaibuchi, K. GSK-3β regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 2005, 120, 137–149. [CrossRef] [PubMed]
57. Read, D.E.; Gorman, A.M. Involvement of Akt in neurite outgrowth. Cell. Mol. Life Sci. 2009, 66, 2975–2984. [CrossRef] [PubMed]
58. Tyler, W.J.; Pozzo-Miller, L. Miniature synaptic transmission and BDNF modulate dendritic spine growth and form in rat CA1 neurones. J. Physiol. 2003, 553(Pt. 2), 497–509. [CrossRef] [PubMed]
59. Castello, N.A.; Nguyen, M.H.; Tran, J.D.; Cheng, D.; Green, K.N.; LaFerla, F.M. 7,8-Dihydroxyflavone, a small molecule TrkB agonist, improves spatial memory and increases thin spine density in a mouse model of Alzheimer disease-like neuronal loss. PLoS ONE 2014, 9, e91453. [CrossRef] [PubMed]
60. Li, Y.; Pehrson, A.L.; Waller, J.A.; Dale, E.; Sanchez, C.; Gulinello, M. A critical evaluation of the activity-regulated cytoskeleton-associated protein (Arc/Arg3.1)’s putative role in regulating dendritic plasticity, cognitive processes, and mood in animal models of depression. Front. Neurosci. 2015, 9, 279. [CrossRef] [PubMed]
61. Peebles, C.L.; Yoo, J.; Thwin, M.T.; Palop, J.J.; Noebels, J.L.; Finkbeiner, S. Arc regulates spine morphology and maintains network stability in vivo. Proc. Natl. Acad. Sci. USA 2010, 107, 18173–18178. [CrossRef] [PubMed]
62. Benson, D.L.; Salton, S.R. Expression and polarization of VGF in developing hippocampal neurons. Brain Res. Dev. Brain Res. 1996, 96, 219–228. [CrossRef]
63. Lombardo, A.; Rabacchi, S.A.; Cremisi, F.; Pizzorusso, T.; Cenni, M.C.; Possenti, R.; Barsacchi, G.; Maffei, L. A developmentally regulated nerve growth factor-induced gene, VGF, is expressed in geniculocortical afferents during synaptogenesis. Neuroscience 1995, 65, 997–1008. [CrossRef]
64. Colle, R.; Deflesselle, E.; Martin, S.; David, D.J.; Hardy, P.; Taranu, A.; Falissard, B.; Verstuyft, C.; Corruble, E. BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients. Pharmacogenomics 2015, 16, 997–1013. [CrossRef] [PubMed]
65. Colle, R.; Gressier, F.; Verstuyft, C.; Deflesselle, E.; Lepine, J.P.; Ferreri, F.; Hardy, P.; Guilloux, J.P.; Petit, A.C.; Feve, B.; et al. Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients. J. Affect. Disord. 2015, 175, 233–240. [CrossRef] [PubMed]
66. Hendrickson, R.C.; Lee, A.Y.; Song, Q.; Liaw, A.; Wiener, M.; Paweletz, C.P.; Seeburger, J.L.; Li, J.; Meng, F.; Deyanova, E.G.; et al. High Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer’s Disease in Human Cerebrospinal Fluid. PLoS ONE 2015, 10, e0135365. [CrossRef] [PubMed]
67. Jahn, H.; Wittke, S.; Zurbig, P.; Raedler, T.J.; Arlt, S.; Kellmann, M.; Mullen, W.; Eichenlaub, M.; Mischak, H.; Wiedemann, K. Peptide fingerprinting of Alzheimer’s disease in cerebrospinal fluid: Identification and prospective evaluation of new synaptic biomarkers. PLoS ONE 2011, 6, e26540. [CrossRef] [PubMed]
68. Lim, Y.Y.; Hassenstab, J.; Cruchaga, C.; Goate, A.; Fagan, A.M.; Benzinger, T.L.; Maruff, P.; Snyder, P.J.; Masters, C.L.; Allegri, R.; et al. BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer’s disease. Brain 2016, 139(Pt. 10), 2766–2777. [CrossRef] [PubMed]
69. Wenzler, S.; Knochel, C.; Balaban, C.; Kraft, D.; Kopf, J.; Alves, G.S.; Prvulovic, D.; Carvalho, A.F.; Oertel-Knochel, V. Integrated Biomarkers for Depression in Alzheimer’s Disease: A Critical Review. Curr. Alzheimer Res. 2017, 14, 441–452. [CrossRef] [PubMed]
70. Musazzi, L.; Treccani, G.; Popoli, M. Functional and structural remodeling of glutamate synapses in prefrontal and frontal cortex induced by behavioral stress. Front. Psychiatry 2015, 6, 60. [CrossRef] [PubMed]
71. Duman, R.S.; Heninger, G.R.; Nestler, E.J. A molecular and cellular theory of depression. Arch. Gen. Psychiatry 1997, 54, 597–606. [CrossRef] [PubMed]
72. Sapolsky, R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 2000, 57, 925–935. [CrossRef] [PubMed]
73. Sheline, Y.I.; Wang, P.W.; Gado, M.H.; Csernansky, J.G.; Vannier, M.W. Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. USA 1996, 93, 3908–3913. [CrossRef] [PubMed]
74. Duman, R.S. Neurobiology of stress, depression, and rapid acting antidepressants: Remodeling synaptic connections. Depression Anxiety 2014, 31, 291–296. [CrossRef] [PubMed]
75. Cattaneo, A.; Gennarelli, M.; Uher, R.; Breen, G.; Farmer, A.; Aitchison, K.J.; Craig, I.W.; Anacker, C.; Zunsztain, P.A.; McGuffin, P.; et al. Candidate genes expression profile associated with antidepressants response in the GENDEP study: Differentiating between baseline ‘predictors’ and longitudinal ‘targets’. Neuropsychopharmacology 2013, 38, 377–385. [CrossRef] [PubMed]
76. McAvoy, K.; Russo, C.; Kim, S.; Rankin, G.; Sahay, A. Fluoxetine induces input-specific hippocampal dendritic spine remodeling along the septotemporal axis in adulthood and middle age. Hippocampus 2015, 25, 1429–1446. [CrossRef] [PubMed]
77. Duman, C.H.; Duman, R.S. Spine synapse remodeling in the pathophysiology and treatment of depression. Neurosci. Lett. 2015, 601, 20–29. [CrossRef] [PubMed]
78. Nibuya, M.; Nestler, E.J.; Duman, R.S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 1996, 16, 2365–2372. [PubMed]
79. Park, S.W.; Lee, J.G.; Seo, M.K.; Cho, H.Y.; Lee, C.H.; Lee, J.H.; Lee, B.J.; Baek, J.H.; Seol, W.; Kim, Y.H. Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons. Bipolar Disord. 2015, 17, 278–290. [CrossRef] [PubMed]
80. Naeve, G.S.; Ramakrishnan, M.; Kramer, R.; Hevroni, D.; Citri, Y.; Theill, L.E. Neuritin: A gene induced by neural activity and neurotrophins that promotes neuritogenesis. Proc. Natl. Acad. Sci. USA 1997, 94, 2648–2653. [CrossRef] [PubMed]
81. Ring, R.H.; Alder, J.; Fennell, M.; Kouranova, E.; Black, I.B.; Thakker-Varia, S. Transcriptional profiling of brain-derived-neurotrophic factor-induced neuronal plasticity: A novel role for nociceptin in hippocampal neurite outgrowth. J. Neurobiol. 2006, 66, 361–377. [CrossRef] [PubMed]
82. Leemhuis, J.; Henle, F.; Meyer, D.K. VIP induces the elongation of dendrites and axons in cultured hippocampal neurons: Role of microtubules. Peptides 2007, 28, 1700–1705. [CrossRef] [PubMed]
83. Pinhasov, A.; Nesher, E.; Gross, M.; Turgeman, G.; Kreinin, A.; Yadid, G. The role of the PACAP signaling system in depression. Curr. Pharm. Des. 2011, 17, 990–1001. [CrossRef] [PubMed]
84. Son, H.; Banasr, M.; Choi, M.; Chae, S.Y.; Licznerski, P.; Lee, B.; Voleti, B.; Li, N.; Lepack, A.; Fournier, N.M.; et al. Neuritin produces antidepressant actions and blocks the neuronal and behavioral deficits caused by chronic stress. Proc. Natl. Acad. Sci. USA 2012, 109, 11378–11383. [CrossRef] [PubMed]
85. Wu, G.Y.; Cline, H.T. Stabilization of dendritic arbor structure in vivo by CaMKII. Science 1998, 279, 222–226. [CrossRef] [PubMed]
86. 2+/CaM-dependent kinase type II triggers upregulation of GluA1 to coordinate adaptation to synaptic inactivity in hippocampal neurons. Proc. Natl. Acad. Sci. USA 2011, 108, 828–833. [CrossRef] [PubMed]
87. Thakker-Varia, S.; Alder, J.; Crozier, R.A.; Plummer, M.R.; Black, I.B. Rab3A is required for brain-derived neurotrophic factor-induced synaptic plasticity: Transcriptional analysis at the population and single-cell levels. J. Neurosci. 2001, 21, 6782–6790. [PubMed]
88. Adzhubei, I.A.; Schmidt, S.; Peshkin, L.; Ramensky, V.E.; Gerasimova, A.; Bork, P.; Kondrashov, A.S.; Sunyaev, S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7, 248–249. [CrossRef] [PubMed]
89. Thomas, P.D.; Campbell, M.J.; Kejariwal, A.; Mi, H.; Karlak, B.; Daverman, R.; Diemer, K.; Muruganujan, A.; Narechania, A. PANTHER: A library of protein families and subfamilies indexed by function. Genome Res. 2003, 13, 2129–2141. [CrossRef] [PubMed]
90. Kumar, P.; Henikoff, S.; Ng, P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 2009, 4, 1073–1081. [CrossRef] [PubMed]